Impact of pazopanib on docetaxel exposure: results of a phase I combination study with two different docetaxel schedules

Research output: Contribution to journalArticleAcademicpeer-review

21 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)365-371
Number of pages7
JournalCancer Chemotherapy & Pharmacology
Volume75
Issue number2
DOIs
Publication statusPublished - 2015

Research programs

  • EMC MM-03-86-01

Cite this